23 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
24513044	19	Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agent.	Bristol-Myers Squibb
24411477	84	Carbamazepine derivatives with P2X4 receptor-blocking activity.	University of Bonn
24164581	82	Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist.	Bristol-Myers Squibb
23510563	9	Synthesis and structure-activity relationships of carboxylic acid derivatives of pyridoxal as P2X receptor antagonists.	Gwangju Institute of Science and Technology
16250663	8	Synthesis and structure-activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency.	University of Bonn
20045645	66	Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.	Roche Palo Alto
23075067	98	N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists.	University of Bonn
11831909	4	Novel antagonists acting at the P2Y(1) purinergic receptor: synthesis and conformational analysis using potentiometric and nuclear magnetic resonance titration techniques.	Universit£
12213051	207	Purine and pyrimidine (P2) receptors as drug targets.	National Institute of Diabetes
19231180	81	Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.	Roche Palo Alto
19231178	61	Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.	Roche Palo Alto
15927468	3	Discovery and synthesis of a novel and selective drug-like P2X(1) antagonist.	Roche Palo Alto
32345019	134	Discovery and Structure Relationships of Salicylanilide Derivatives as Potent, Non-acidic P2X1 Receptor Antagonists.	University of Bonn
27427902	93	Potent Suppressive Effects of 1-Piperidinylimidazole Based Novel P2X7 Receptor Antagonists on Cancer Cell Migration and Invasion.	Gwangju Institute of Science and Technology (Gist)
30996785	44	Investigation on 2',3'-	University of Camerino
31746599	78	Discovery and Characterization of the Potent and Selective P2X4 Inhibitor	Bayer
26460788	45	Novel Series of Dihydropyridinone P2X7 Receptor Antagonists.	Hoffmann-La Roche
29649742	55	Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells.	Gwangju Institute of Science and Technology (Gist)
29805055	40	Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 1: Initial structure-activity relationship studies of a hit from a high throughput screening.	Shionogi
26833890	18	Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease.	Yogi Vemana University
26469307	7	Phosphorylation of Capsaicinoid Derivatives Provides Highly Potent and Selective Inhibitors of the Transcription Factor STAT5b.	University of Leipzig